Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.92 USD | -.--% | -0.43% | -6.49% |
Chart calendar Pasithea Therapeutics Corp.
Upcoming events on Pasithea Therapeutics Corp.
Past events on Pasithea Therapeutics Corp.
28/12/2023 | Annual General Meeting |
19/12/2023 14:00 | Annual General Meeting |
11/09/2023 05:00 | H.C. Wainwright Global Investment Conference |
26/06/2023 00:00 | Neurofibromatosis Conference |
09/05/2023 | EF Hutton Global Conference |
04/03/2023 16:30 | American Association Advancement of Science Meeting |
22/02/2023 | Americas Committee for Treatment and Research in Multiple Sclerosis Forum |
08/12/2022 | Extraordinary Shareholders Meeting - Proxy Fight |
06/12/2022 | Antibody Engineering & Therapeutics Conference |
29/11/2022 14:00 | Extraordinary Shareholders Meeting |
13/10/2022 | Immunotherapy International Course and Symposium |
12/10/2022 14:00 | Acquisition of AlloMek Therapeutics LLC By Pasithea Therapeutics Corp Call |
12/09/2022 12:00 | H.C. Wainwright Global Investment Conference |
30/08/2022 14:00 | From Laboratory to Clinic International Conference |
27/06/2022 15:30 | H.C. Wainwright Mental Healthcare Conference |
23/06/2022 14:00 | Annual General Meeting |
22/06/2022 14:00 | Acquisition of Alpha-5 integrin, LLC by Pasithea Therapeutics Corp Call |
21/04/2022 17:30 | NobleCon18 Conference |
30/03/2022 21:15 | FY 2021 Earnings Release |
30/09/2021 15:10 | Benzinga Healthcare Small Cap Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,02 0,10 -84.94% | 0,49 0,50 -2.69% |
EBITDA Million USD | Released Forecast Spread | 0,00 | -4,51 -2,90 -55.38% | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -4,51 -3,30 -36.59% | 0,00 0,00 - |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
Net income Million USD | Released Forecast Spread | -0,04 | 0,00 0,00 - | 0,00 0,00 - |
EPS USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
Announcement Date | 13/04/21 | 30/03/22 | 30/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,02 0,10 -84.94% | 0,01 0,30 -95.45% | 0,01 0,50 -97.28% | 0,22 0,10 118.61% | 0,24 0,30 -19.76% | 0,00 0,00 - | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | -1,96 -0,70 -180% | -2,40 -1,50 -59.97% | -2,51 -2,50 -0.4% | ||||
EBIT Million USD | Released Forecast Spread | -1,96 -0,80 -144.53% | -3,08 -2,60 -18.47% | |||||
Announcement Date | 30/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 12/05/23 | 11/08/23 |
Past sector events for Pasithea Therapeutics Corp.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- KTTA Stock
- Calendar Pasithea Therapeutics Corp.